Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Central Memory T-Cell Differentiation Correlates with Depth of Response in Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab in Combination with Carfilzomib, Lenalidomide and Dexamethasone (Elo-KRd)

David M Foureau, Manisha Bhutani, Fei Guo, Kateryna Fesenkova, Shebli Atrash, Reed Friend, Barry Paul, Myra M Robinson, James T Symanowski, Lawrence J Druhan, Mauricio Pineda-Roman, Peter M. Voorhees, Saad Z. Usmani

Blood (2021) 138 (Supplement 1): 1585.

https://doi.org/10.1182/blood-2021-152505

Published: 2021

Journal Articles

Risk Factors for Thromboembolism (TE) in Multiple Myeloma (MM) Patients (pts) Treated with Immunomodulatory Agents (IMiDs) Plus Dexamethasone (dex)

Jai N Patel, PharmD, BCOP, Megan Helena Jagosky, MD, Myra M Robinson, MSPH, Daniel Slaughter, Justin Arnall, PharmD, CPP, BCOP, Ashley Matusz-Fisher, MD, Manisha Bhutani, MD, Peter M. Voorhees, MD, Saad Z. Usmani, MD

Blood (2018) 132 (Supplement 1): 4814.

https://doi.org/10.1182/blood-2018-99-118283

Published: 2018

Journal Articles

Prognostic Significance of Tracking Dynamic Changes in Positron Emission Tomography (PET) Scan Pre and Post Autologous Stem Cell Transplant (ASCT)

Shebli Atrash, Myra M Robinson, MSPH, Manisha Bhutani, MD, Daniel Slaughter, Issam S. Hamadeh, PharmD, Peter M. Voorhees, MD, Jill Eddy, Lauren Minard, Reed Freind, Jordan Robinson, NDaiye AMI, Chelsea Sprouse, James Symanowski, PhD, Maham Khan, Belinda Rene Avalos, MD, Rajesh Banderudrappagari, Justin Arnall, PharmD, CPP, BCOP, Edward A. Copelan, MD, Saad Z. Usmani, MD

Blood (2018) 132 (Supplement 1): 5582.

https://doi.org/10.1182/blood-2018-99-118099

Published: 2018

Journal Articles

Impact of Body Mass Index (BMI) on the Incidence of Bortezomib -Induced Peripheral Neuropathy (BIPN) in Patients with Newly Diagnosed Multiple Myeloma (MM)

Ala'a Muslimani, MD, Donald C Moore, PharmD, BCPS, BCOP, DPLA, Tanner Ringley, PharmD, BCOP, Myra M Robinson, MSPH

Blood (2018) 132 (Supplement 1): 2002.

https://doi.org/10.1182/blood-2018-99-110255

Published: 2018

Journal Articles

Peripheral Cellular Immunome Reveals Heterogeneity Spanning Myeloma Spectrum Diseases

Manisha Bhutani, MD, David M Foureau, PhD, Qing Zhang, PhD, Myra M Robinson, MSPH, Adina Wynn, Nury M Steuerwald, PhD, Lawrence J Druhan, PhD, Fei Guo, PhD, Katherine Rigby, Mitchell Turner, Reed Friend, MD, Shebli Atrash, Ami Ndiaye, Chelsea Sprouse, James T Symanowski, PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD, Peter M. Voorhees, MD, Saad Z Usmani, MD

Blood (2017) 130 (Supplement 1): 3054.

https://doi.org/10.1182/blood.V130.Suppl_1.3054.3054

Published: 2017

Journal Articles

Outcomes of Patients with Newly Diagnosed Aggressive B Cell Lymphoma Presenting with Hepatic and/ or Renal Dysfunction

Nilanjan Ghosh, MD PhD, Jigar Trivedi, MSc, PharmD, Srinivasa Reddy Sanikommu, MD, Myra M Robinson, MSPH, Ryan Jacobs, MD, Steven I Park, MD, Danyu Sun, MD PhD, James T Symanowski, PhD, Taylor Brown, BS, MS, Belinda Rene Avalos, MD, Edward A Copelan, MD

Blood (2017) 130 (Supplement 1): 5225.

https://doi.org/10.1182/blood.V130.Suppl_1.5225.5225

Published: 2017

Journal Articles

Prognostic Significance of Ki67 Expression By Immunohistochemistry (IHC) on Bone Marrow Biopsy in Newly Diagnosed Multiple Myeloma

Myra M Robinson, MSPH, Shebli Atrash, Taylor Brown, BS, MS, Jared G Block, MD, Edward H Lipford, MD, Elton T Smith, MD, Reed Friend, MD, Amanda Aneralla, Alankrita Taneja, MD, Qing Zhang, PhD, David M Foureau, PhD, Chelsea Sprouse, Ami Ndiaye, James T Symanowski, PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD, Peter M. Voorhees, MD, Saad Z Usmani, MD, Manisha Bhutani, MD

Blood (2017) 130 (Supplement 1): 4348.

https://doi.org/10.1182/blood.V130.Suppl_1.4348.4348

Published: 2017

Journal Articles

Effect of Immunomodulatory Drugs (IMiDs) on Immune Effectors after Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma

David M Foureau, PhD, Manisha Bhutani, MD, Qing Zhang, PhD, Myra M Robinson, MSPH, Adina Wynn, Nury M Steuerwald, PhD, Lawrence J Druhan, PhD, Fei Guo, PhD, Katherine Rigby, Mitchell Turner, Reed Friend, MD, Shebli Atrash, Chelsea Sprouse, Ami Ndiaye, James T Symanowski, PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD, Peter M. Voorhees, MD, Saad Z Usmani, MD

Blood (2017) 130 (Supplement 1): 1817.

https://doi.org/10.1182/blood.V130.Suppl_1.1817.1817

Published: 2017

Journal Articles

Validation of Dynamic Biomarker-Based Risk Progression Model for Smoldering Multiple Myeloma

Shebli Atrash, Myra M Robinson, MSPH, Amanda Aneralla, Taylor Brown, BS, MS, Reed Friend, MD, Chelsea Sprouse, Ami Ndiaye, Qing Zhang, PhD, Edward H Lipford, MD, Jared G Block, MD, Elton T Smith, MD, James T Symanowski, PhD, Belinda Rene Avalos, MD, Edward A Copelan, MD, Peter M. Voorhees, MD, Saad Z Usmani, MD, Manisha Bhutani, MD

Blood (2017) 130 (Supplement 1): 1779.

https://doi.org/10.1182/blood.V130.Suppl_1.1779.1779

Published: 2017

Journal Articles

Frontline Azacitidine As a Bridge to Allogeneic Transplantation in Acute Myeloid Leukemia

Michael Richard Grunwald, MD, Michael Keith Allister Zimmerman, MS, Danielle Boselli, MS, Lauren M. Bohannon, Myra M Robinson, MSPH, Daniel T. Peters, Jing Ai, MD PhD, Thomas G. Knight, MD, Jigar Trivedi, MSc, PharmD, Dragos Plesca, PharmD, James T Symanowski, PhD, Edward A Copelan, MD, Jonathan M. Gerber, MD

Blood (2017) 130 (Supplement 1): 3864.

https://doi.org/10.1182/blood.V130.Suppl_1.3864.3864

Published: 2017

Journal Articles

CYP2C19 Genotype-Guided Dosing and Voriconazole Concentrations in Hematopoietic Stem Cell Transplant Patients (HSCT) Receiving Antifungal Prophylaxis

Jai N Patel, PharmD, Myra M Robinson, Issam Hamadeh, PharmD, Zainab Shahid, MD, James T Symanowski, PhD, Dragos Plesca, PharmD, PhD, Margaret Croom, PharmD, Jigar Trivedi, MSc, PharmD, Nury M. Steuerwald, PhD, Belinda R. Avalos, MD, Edward A. Copelan, MD FACP

Blood (2016) 128 (22): 3416.

https://doi.org/10.1182/blood.V128.22.3416.3416

Published: 2016

Journal Articles

Fluorescence in Situ Hybridization (FISH) abnormalities and Baseline Clinical Features at Diagnosis in African American Multiple Myeloma Patients

Megan H Jagosky, MD, Kyle L Madden, BS, Blake B Goodbar, MD, Virginia Thurston, PhD, Manisha Bhutani, MD, Preeya Patel, BS, Myra M Robinson, Rupali Bose, Jill Eddy, Candice G Roth, RN, MSN, Lynn S Sanders, MSN, RN, OCN, James T Symanowski, PhD, Tammy D Cogdill, NP, Belinda R. Avalos, MD, Edward A. Copelan, MD FACP, Saad Z Usmani, MD FACP

Blood (2016) 128 (22): 2351.

https://doi.org/10.1182/blood.V128.22.2351.2351

Published: 2016

Journal Articles

Outcomes in Transplant Eligible Multiple Myeloma African American Patients Appear Similar to Caucasian Patients

Megan H Jagosky, MD, Kyle L Madden, BS, Myra M Robinson, Blake B Goodbar, MD, Manisha Bhutani, MD, Preeya Patel, BS, Rupali Bose, Jill Eddy, Sarah LeStrange, Candice G Roth, RN, MSN, Lynn S Sanders, MSN, RN, OCN, James T Symanowski, PhD, Tammy D Cogdill, NP, Dragos Plesca, PharmD, PhD, Belinda R. Avalos, MD, Edward A. Copelan, MD FACP, Saad Z Usmani, MD FACP

Blood (2016) 128 (22): 2352.

https://doi.org/10.1182/blood.V128.22.2352.2352

Published: 2016

Journal Articles

Distribution of Cytogenetic Abnormalities in African American Multiple Myeloma Patients May be Unique for Different Geographic Regions

Manisha Bhutani, MD, Preeya Patel, BS, Myra M Robinson, Rupali Bose, Kyle Madden, BS, Jill Eddy, Candice G Roth, RN, MSN, James Symanowski, Tammy Cogdill, NP, Jordan Robinson, PA-C, Belinda R Avalos, MD, Edward A. Copelan, MD, Saad Z Usmani, MD FACP

Blood (2015) 126 (23): 5337.

https://doi.org/10.1182/blood.V126.23.5337.5337

Published: 2015

NARROW

Central Memory T-Cell Differentiation Correlates with Depth of Response in Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab in Combination with Carfilzomib, Lenalidomide and Dexamethasone (Elo-KRd)

Risk Factors for Thromboembolism (TE) in Multiple Myeloma (MM) Patients (pts) Treated with Immunomodulatory Agents (IMiDs) Plus Dexamethasone (dex)

Prognostic Significance of Tracking Dynamic Changes in Positron Emission Tomography (PET) Scan Pre and Post Autologous Stem Cell Transplant (ASCT)

Impact of Body Mass Index (BMI) on the Incidence of Bortezomib -Induced Peripheral Neuropathy (BIPN) in Patients with Newly Diagnosed Multiple Myeloma (MM)

Peripheral Cellular Immunome Reveals Heterogeneity Spanning Myeloma Spectrum Diseases

Outcomes of Patients with Newly Diagnosed Aggressive B Cell Lymphoma Presenting with Hepatic and/ or Renal Dysfunction

Prognostic Significance of Ki67 Expression By Immunohistochemistry (IHC) on Bone Marrow Biopsy in Newly Diagnosed Multiple Myeloma

Effect of Immunomodulatory Drugs (IMiDs) on Immune Effectors after Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma

Validation of Dynamic Biomarker-Based Risk Progression Model for Smoldering Multiple Myeloma

Frontline Azacitidine As a Bridge to Allogeneic Transplantation in Acute Myeloid Leukemia

CYP2C19 Genotype-Guided Dosing and Voriconazole Concentrations in Hematopoietic Stem Cell Transplant Patients (HSCT) Receiving Antifungal Prophylaxis

Fluorescence in Situ Hybridization (FISH) abnormalities and Baseline Clinical Features at Diagnosis in African American Multiple Myeloma Patients

Outcomes in Transplant Eligible Multiple Myeloma African American Patients Appear Similar to Caucasian Patients

Distribution of Cytogenetic Abnormalities in African American Multiple Myeloma Patients May be Unique for Different Geographic Regions

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only